Understanding the virulence of Streptococcus suis: A veterinary, medical, and economic challenge.
Haas B, Grenier D.
Med Mal Infect. 2018 May;48(3):159-166. doi: 10.1016/j.medmal.2017.10.001. Epub 2017 Nov 6.
Streptococcus suis infection.
Huang YT, Teng LJ, Ho SW, Hsueh PR.
J Microbiol Immunol Infect. 2005 Oct;38(5):306-13.
Streptococcus suis serotype 4: a population with the potential pathogenicity in humans and pigs.
Zhu J, Wang J, Kang W, Zhang X, Kerdsin A, Yao H, Zheng H, Wu Z.
Emerg Microbes Infect. 2024 Dec;13(1):2352435. doi: 10.1080/22221751.2024.2352435. Epub 2024 May 15.
[Human infection due to Streptococcus suis].
Gao ZY, Zhuang H.
Zhonghua Liu Xing Bing Xue Za Zhi. 2005 Sep;26(9):645-8.
Human Streptococcus suis Infections, South America, 1995-2024.
Bakpatina-Batako MVP, Li K, Lacouture S, Cipolla L, Gianecini A, Prieto M, Gottschalk M, Fittipaldi N.
Emerg Infect Dis. 2025 Jul;31(7):1277-1286. doi: 10.3201/eid3107.241835.
Case report: One human Streptococcus suis infection in Shandong Province, China.
Liu Y, Kou Z, Wang X, Chen S, Li R, Wang Q.
Medicine (Baltimore). 2023 Apr 7;102(14):e33491. doi: 10.1097/MD.0000000000033491.
Streptococcus suis: an emerging human threat.
Segura M.
J Infect Dis. 2009 Jan 1;199(1):4-6. doi: 10.1086/594371.
Spinal canal infection caused by Streptococcus suis in human: a case report.
Xu L, Wang X, Lei Z, Zhu J, Pang Y, Liu J.
BMC Infect Dis. 2022 Apr 12;22(1):369. doi: 10.1186/s12879-022-07353-y.
Risk factors for Streptococcus suis infection: A systematic review and meta-analysis.
Rayanakorn A, Goh BH, Lee LH, Khan TM, Saokaew S.
Sci Rep. 2018 Sep 6;8(1):13358. doi: 10.1038/s41598-018-31598-w.
Theaflavin Ameliorates Streptococcus suis-Induced Infection In Vitro and In Vivo.
Gao T, Tan Y, Wang Y, Yuan F, Liu Z, Yang K, Liu W, Guo R, Li C, Tian Y, Zhou D.
Int J Mol Sci. 2023 Apr 18;24(8):7442. doi: 10.3390/ijms24087442.
